Cardinal Health, Inc. Stock price

Equities

CAH

US14149Y1082

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-18 pm EDT 5-day change 1st Jan Change
110.2 USD -0.41% Intraday chart for Cardinal Health, Inc. -4.61% +9.29%
Sales 2024 * 227B Sales 2025 * 246B Capitalization 26.9B
Net income 2024 * 1.23B Net income 2025 * 1.6B EV / Sales 2024 * 0.12 x
Net cash position 2024 * 181M Net cash position 2025 * 752M EV / Sales 2025 * 0.11 x
P/E ratio 2024 *
19.1 x
P/E ratio 2025 *
16 x
Employees 47,520
Yield 2024 *
1.84%
Yield 2025 *
1.87%
Free-Float 74.09%
More Fundamentals * Assessed data
Dynamic Chart
Cardinal Health Gains Approval for Science-Based Targets to Cut Greenhouse Gas Emissions MT
Transcript : Cardinal Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM
Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024 CI
Leerink Partners Starts Cardinal Health With Outperform Rating, $125 Price Target MT
US FTC, DHHS Request Information on Shortages of Generic Drugs; McKesson Shares Ease MT
Binx health, inc. Enters into National Distribution Agreement with Cardinal Health to Increase Access to the CLIA-Waived, FDA-Cleared binx io CI
North American Morning Briefing : Stock Futures -2- DJ
Argus Upgrades Cardinal Health to Buy From Hold, Price Target is $120 MT
Cardinal Health Keeps Quarterly Dividend at $0.5006 a Share, Payable April 15 to Shareholders of Record April 1 MT
Cardinal Health Approves Quarterly Dividend, Payable on April 15, 2024 CI
Precipio, Inc. and Cardinal Health Sign Distribution Agreement for Its HemeScreen®? Portfolio of Molecular Assays for Cancer CI
UBS Adjusts Cardinal Health Price Target to $125 From $122, Maintains Buy Rating MT
Tranche Update on Cardinal Health, Inc.'s Equity Buyback Plan announced on June 8, 2023. CI
Tranche Update on Cardinal Health, Inc.'s Equity Buyback Plan announced on November 9, 2021. CI
Cardinal Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
More news
1 day-0.41%
1 week-4.35%
Current month-1.63%
1 month+5.47%
3 months+9.62%
6 months+25.54%
Current year+9.29%
More quotes
1 week
108.59
Extreme 108.59
116.04
1 month
104.45
Extreme 104.45
116.04
Current year
100.36
Extreme 100.36
116.04
1 year
68.53
Extreme 68.53
116.04
3 years
45.85
Extreme 45.85
116.04
5 years
39.05
Extreme 39.0508
116.04
10 years
39.05
Extreme 39.0508
116.04
More quotes
Managers TitleAgeSince
Chief Executive Officer 51 20-04-26
Director of Finance/CFO 53 23-02-09
Chief Tech/Sci/R&D Officer - 20-12-31
Members of the board TitleAgeSince
Director/Board Member 55 22-09-05
Director/Board Member 71 13-09-11
Chairman 71 06-12-31
More insiders
Date Price Change Volume
24-03-18 110.2 -0.41% 3,650,061
24-03-15 110.6 +0.62% 4,425,346
24-03-14 109.9 -1.04% 3,348,883
24-03-13 111.1 -3.93% 4,522,830
24-03-12 115.6 +0.12% 1,963,329

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (92.7%); - distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.). The United States accounts for 97.7% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
110.2 USD
Average target price
113.3 USD
Spread / Average Target
+2.86%
Consensus
  1. Stock
  2. Equities
  3. Stock Cardinal Health, Inc. - Nyse